These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4039618)

  • 21. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
    Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of chronic clorgyline and amfonelic acid on desensitization of striatal dopamine receptors.
    Meller E; Bohmaker K; Friedhoff AJ
    Life Sci; 1984 Oct; 35(18):1829-38. PubMed ID: 6492992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of chronic haloperidol, thioridazine and zotepine treatment on apomorphine elicited stereotypic behavior and 3H-spiroperidol binding sites in the striatum of the rat.
    Lai HC; Carino MA; Horita A
    Proc West Pharmacol Soc; 1981; 24():5-6. PubMed ID: 6114496
    [No Abstract]   [Full Text] [Related]  

  • 24. Are the catecholestrogens involved in estrogen-induced striatal dopamine receptor supersensitivity?
    Ferretti C; Ghi P; Blengio M; Gaietta G; Barrera G; Genazzani E
    Eur J Pharmacol; 1989 Jul; 166(2):149-56. PubMed ID: 2551698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation.
    Carvey PM; Hitri A; Goetz CG; Tanner CM; Klawans HL
    Life Sci; 1988; 42(22):2207-15. PubMed ID: 3374255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of dopaminergic supersensitization using apomorphine-induced behavior in the mouse.
    Randall PK
    Life Sci; 1985 Oct; 37(15):1419-23. PubMed ID: 4046742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Permanent haloperidol-induced dopamine receptor up-regulation in the ovariectomized rat.
    Fields JZ; Gordon JH
    Brain Res Bull; 1991 Apr; 26(4):549-52. PubMed ID: 1831063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of beta-/Tyr9/melanotropin-/9-18/ on apomorphine-induced stereotyped cage-climbing and on striatal dopamine release in mice. Comparative studies with amphetamine.
    Vécsei L; Telegdy G; Schally AV; Coy DH
    Neuropeptides; 1982 Dec; 3(2):91-6. PubMed ID: 6891751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic treatments with zotepine, thioridazine, and haloperidol affect apomorphine-elicited stereotypic behavior and striatal 3H-spiroperidol binding sites in the rat.
    Lai H; Carino MA; Horita A
    Psychopharmacology (Berl); 1981; 75(4):388-90. PubMed ID: 6122233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes.
    Thal L; Mishra RK; Gardner EL; Horowitz SG; Varmuza S; Makman MH
    Brain Res; 1979 Jul; 170(2):381-6. PubMed ID: 572733
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of dopamine receptor agonist treatment on haloperidol-induced supersensitivity in mice.
    Fayle P; Jackson DM; Jenkins OF; Lafferty PA
    Pharmacol Biochem Behav; 1985 Nov; 23(5):715-20. PubMed ID: 4080755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral demonstration of a reciprocal interaction between dopamine receptor subtypes in the mouse striatum: possible involvement of the striato-nigral pathway.
    Mandel RJ; Yurek DM; Randall PK
    Brain Res Bull; 1990 Aug; 25(2):285-92. PubMed ID: 2146002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity.
    Carvey PM; Kao LC; Zhang TJ; Amdur RL; Lin DH; Singh R; Klawans HL
    Pharmacol Biochem Behav; 1990 Feb; 35(2):291-300. PubMed ID: 2320636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced dopaminergic binding during aging in the rodent striatum.
    Severson JA; Finch CE
    Brain Res; 1980 Jun; 192(1):147-62. PubMed ID: 6155174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Striatal depth EEG reveals postsynaptic activity of striatal neurons following dopamine receptor stimulation and blockade.
    Yurek DM; Randall PK
    J Neurosci Methods; 1991 Mar; 37(1):81-91. PubMed ID: 2072738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine receptors in the striatum and limbic system of various strains of mice: relation to differences in responses to apomorphine.
    Michaluk J; Antkiewicz-Michaluk L; Rokosz-Pelc A; Sansone M; Oliverio A; Vetulani J
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1115-8. PubMed ID: 6891791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.
    Prosser ES; Pruthi R; Csernansky JG
    Psychopharmacology (Berl); 1989; 99(1):109-16. PubMed ID: 2506596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral and neurochemical modifications induced by apomorphine treatment.
    Piervincenzo P; Luciana G; Laura C; Giuseppe A
    Neurosci Lett; 1989 May; 100(1-3):265-70. PubMed ID: 2761776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine-mediated behaviour and 3H-spiperone binding to striatal membranes in rats after nine months haloperidol administration.
    Owen F; Cross AJ; Waddington JL; Poulter M; Gamble SJ; Crow TJ
    Life Sci; 1980 Jan; 26(1):55-9. PubMed ID: 7189005
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.
    Kovács GL; Szabó G; Penke B; Telegdy G
    Eur J Pharmacol; 1981 Jan; 69(3):313-9. PubMed ID: 6260512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.